Novartis India has announced that its Board has approved the appointment of M/s. D.C.

Dave & Co., a firm of Practicing Cost Accountants, as the company's Cost Auditor.

This appointment is for the financial year 2025-26, effective from April 1, 2025. This move is crucial for ensuring the company's cost compliance and robust financial oversight.

The remuneration for the newly appointed auditors will be subject to approval by shareholders through a Postal Ballot.